Biologics, Inc. (Biopharma, Biotechnology) — Funding, Investors & Signals 2026

Biologics, Inc.

Founded 1994

Cary, United States 135 employees Series Unknown Total: $29.82M Biopharma, Biotechnology +2

Biologics, Inc., founded in 1994, has recently been acquired by McKesson Corporation, a leader in the healthcare industry headquartered in the United States. McKesson, currently ranked 5th on the FORTUNE 500, is known for its dedication to improving the business of healthcare through healthcare services and information technology. The acquisition is expected to expedite access to oncology therapies and better support patients. This acquisition comes after Biologics' last investment of $29.00M in a Venture Round on 15 April 2015. Although details about the specific investors behind this round are not provided, the company has attracted significant investment in the past, aligning with its involvement in Biopharma, Biotechnology, Finance, and Health Care industries. With this transition into the McKesson Corporation, Biologics, Inc. is set to leverage its expertise within the healthcare sector along with the support and resources of a Fortune 500 company to further enhance its financial, operational, and clinical performance and contribute to the betterment of the healthcare industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	••••••	-		15 Apr 2015
Venture Round	••••••	-		20 May 2010

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

••••••

15 Apr 2015

Venture Round

••••••

20 May 2010

FAQ About Biologics, Inc.

Biologics, Inc. is now a part of McKesson Corporation. Our combined organization will help better support patients and expedite access to oncology therapies. Please continue to work with your dedicated sales representative and stay tuned for additional information on the integration. McKesson Cor...

Biologics, Inc. was founded in 1994.

Biologics, Inc. is headquartered in Cary, United States.

Biologics, Inc. operates in the following industries: Biopharma, Biotechnology, Finance, Health Care.

Biologics, Inc. has approximately 135 employees.

Biologics, Inc. has completed 2 funding rounds, raising a total of $29.82M. The latest funding stage is Series Unknown.

Top alternatives and competitors to Biologics, Inc. include USRetina, LogicStream Health Inc., Magentus, HealthCare Strategies, McKesson. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Biologics, Inc. and USRetina are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Biologics, Inc.

General Information

Track Biologics, Inc.

Discover More

About Biologics, Inc.

Funding Rounds & Investors (2)

Biologics, Inc. Alternatives & Competitors

FAQ About Biologics, Inc.

Don't just browse. Track.